USADA announced today that Danielle Rante, of Dayton, Ohio, an athlete in the sport of weightlifting, has accepted a four-year suspension for an anti-doping rule violation. Rante, 40, tested positive for 19-norandrosterone (19-NA), the main urinary metabolite of nandrolone (19-nortestosterone) and other 19-norsteroids, as a result of an out-of-competition drug test conducted on March 4, 2020.

19-NA is a Non-Specified Substance in the class of Anabolic Agents and is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policies, and the International Weightlifting Federation Anti-Doping Policy, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Anabolic agents have powerful performance-enhancing capabilities and can give an athlete an unfair advantage over fellow competitors.

Rante’s four-year period of ineligibility began on March 4, 2020, the date her positive sample was collected. In addition, Rante has been disqualified from all competitive results obtained on and subsequent to March 4, 2020, including forfeiture of any medals, points and prizes.

• This media release was published by the US Anti-Doping Agency (USADA) on 22 July 2020. Click here for the original.